For millions of Americans, popping one or two daily low-dose (81 mg) aspirin pills is an easy way to help prevent heart attacks and strokes.
What most people don’t realize: Even though this type of “aspirin therapy” has been used since the 1970s in the US, the majority of patients—as well as many doctors—aren’t aware that the drug may not be doing the job for all of those taking it. That’s because 15% to 25% of Americans are “aspirin-resistant” and may not fully respond to the drug’s cardioprotective properties.
It’s troubling because aspirin (typically 81 mg to 162 mg daily) is routinely prescribed for heart patients. Research shows that daily aspirin therapy can reduce the risk for second heart attacks in men and women by about 25% and the risk for second strokes by about 22%.
Recent development: Even though the evidence has long been unclear whether aspirin helps prevent a first heart attack or stroke in both sexes, the American Heart Association has recently recommended that low-dose aspirin therapy be considered in adults age 50 and older who have a 10-year cardiovascular risk of at least 10% but no increased risk for bleeding.* (Uncontrolled high blood pressure and diabetes are among the factors that increase one’s 10-year risk.)
Those who are aspirin-resistant, however, face the risks associated with aspirin therapy (mainly gastric bleeding and, in rare cases, hemorrhagic stroke)—without any appreciable gain in long-term health. Key facts about aspirin therapy…
A daily aspirin prevents blood platelets from clumping and forming clots—the cause of most heart attacks and strokes. But what happens when it doesn’t work?
Troubling research: A recent study found that aspirin-resistance in some patients could be linked to a tripling (or more) of major cardiovascular events. This doesn’t mean that aspirin isn’t an effective treatment. It does work for the majority of patients who take it for its cardioprotective benefits.
But if you don’t respond to aspirin…or respond just a little, there may still be a solution.**
Some experts believe that aspirin resistance may not be due to physiological reasons—but instead mainly from improper use.
Example: Many people who take aspirin for cardiovascular health also take other nonsteroidal anti–inflammatory drugs (NSAIDs)—such as ibuprofen (Motrin) or naproxen (Aleve)—for unrelated conditions. These drugs are believed to antagonize (block) the clot-inhibiting effects of aspirin. Other possibilities…
Blood tests can readily detect the effects of aspirin on platelet aggregation, part of the sequence that leads to clotting. The tests are routinely performed on patients who are scheduled for stents or other cardiac procedures. However, they’re not commonly used to check for aspirin resistance.
My advice: Anyone who takes aspirin to prevent heart attack or stroke should ask his/her doctor if platelet function testing is needed—and how often. The tests are quick and typically covered by insurance. Your doctor needs to know if you’re not responding to aspirin so that he can recommend other approaches (such as those described below) to reduce your clot risks. What helps…
*To calculate your 10-year risk for heart attack or stroke, go to CVRiskCalculator.com.
**Important: Never start or stop aspirin therapy without consulting your doctor.